Novartis has another phase 3 trial win in its quiver for targeted factor B inhibitor iptacopan, building the case for the drug as a new oral therapy for diseases caused by disorders of the complement ...

In Kelly Hertz’s column (Press & Dakotan, Jan. 30), I completely agree with what was said about us becoming hardened to watching death on live TV. But there is now an element that I could never have ...

Meditation is for everyone — whether you’re just beginning or have years of practice. It offers powerful benefits that support your well-being: easing stress, improving sleep, and fostering a sense of ...

Sir Jim Ratcliffe insists the tough decisions that have made him “unpopular” at Manchester United are now beginning to show results. Since buying into the Premier League club two years ago, the United ...